CTAS monthly performance report
Monthly CTAS research: returns, drawdown, relative strength, seasonality, and key stats.
CTAS monthly report
—
Key takeaways
- Cintas (CTAS) closed September 2026 at $200.59, down 0.59% for the month and −4.49% over the trailing 12 months.
- Year-to-date, CTAS is +6.66%, underperforming the S&P 500 which has returned +11.71% YTD.
- The stock is trading +7.39% versus its 200-day moving average ($186.79), a bullish technical signal.
- Over the past three years, CTAS has underperformed the S&P 500 by −10.04%, with a relative strength index reading of 94.1.
- Win rate over the trailing 39 months stands at 64.1% — 25 positive months versus 14 negative months.
Cintas ended September 2026 at $200.59, posting a monthly return of −0.59%. The S&P 500 returned −0.69% over the same window, leaving relative performance at +0.09%.
The current quarter stands at +17.06% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +7.39% versus the 200-day moving average ($186.79).
Year-to-date, CTAS is +6.66% against SPY +11.71%, a gap of −5.05%. The stock is currently −8.47% below its 52-week high, with maximum 3-year drawdown at −28.16%.
| Period | CTAS | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.59% | −0.69% | +0.09% |
| 1 Week | −2.04% | −0.54% | −1.50% |
| 1 Month | −0.59% | −0.69% | +0.09% |
| 3 Months | +17.13% | +0.70% | +16.43% |
| 6 Months | +1.17% | +10.52% | −9.35% |
| YTD | +6.66% | +11.71% | −5.05% |
| 12 Months | −4.49% | +18.10% | −22.59% |
| 3 Years | +58.80% | +68.84% | −10.04% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +19.27% |
| #2 | Mar 2024 | +10.78% |
| #3 | Nov 2024 | +9.63% |
| #4 | Jan 2025 | +9.25% |
| #5 | Dec 2023 | +8.93% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2024 | −18.95% |
| #2 | Mar 2026 | −15.55% |
| #3 | Oct 2025 | −10.19% |
| #4 | Aug 2025 | −5.65% |
| #5 | Sep 2023 | −5.42% |
| Quarter | Return |
|---|---|
| Q2 2025 | +9.85% |
| Q3 2025 | −7.42% |
| Q4 2025 | −7.26% |
| Q1 2026 | −9.25% |
| Q2 2026 | +0.36% |
| Q3 2026 (QTD) | +17.06% |
| Year | Return |
|---|---|
| 2023 | +34.41% |
| 2024 | +23.14% |
| 2025 | +4.95% |
| 2026 | +6.61% |
| Metric | Value |
|---|---|
| 52-Week High | $219.16 (2026-07-29) |
| 52-Week Low | $161.16 (2026-05-13) |
| Current Price | $200.59 |
| 200-Day Moving Average | $186.79 |
| Price vs 200DMA | +7.39% |
| 3-Year Maximum Drawdown | −28.16% (2026-05-13) |
| Current Drawdown from 52W High | −8.47% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 94.1 |
| 3-Year Excess Return vs S&P 500 | −10.04% |
| RS Peak | 139.6 (Apr 2025) |
| RS Trough | 78.7 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CTAS's return for this report period?
CTAS returned −0.59% in the latest monthly window ending 2026-09-01.
Has CTAS outperformed SPY year to date?
YTD CTAS: +6.66% vs SPY: +11.71%.
What is CTAS's 12-month return?
−4.49% over the trailing 12 months.
Is CTAS above or below its 200-day moving average?
Price is +7.39% versus 200DMA ($186.79).
What is the maximum drawdown in the 3-year window?
−28.16% on 2026-05-13.